List view / Grid view

Verastem

 

news

Verastem reduces its workforce by 50%

9 October 2015 | By Victoria White

Verastem’s announcement comes just weeks after the company had to abandon enrolment in a Phase 2 study of its lead cancer drug VS-6063...